Form 4: Labcorp Director Sells 500 Shares Under Pre-Arranged Trading Plan

A director at Labcorp Holdings Inc. has sold 500 shares of common stock for $260 per share, as part of a pre-arranged Rule 10b5-1 trading plan.

Summary

• Kerrii B. Anderson, a Director at Labcorp Holdings Inc. (LH), disposed of 500 shares of common stock.
• The transaction occurred on June 11, 2025, with shares sold at a price of $260 per share.
• Following this transaction, Ms. Anderson directly beneficially owns 12,666 shares of common stock.
• Additionally, Ms. Anderson indirectly beneficially owns 144 shares through the Alexa M. Anderson Separate Trust and another 144 shares through the Cameron Taff Anderson Separate Trust.
• The sale was executed pursuant to a Rule 10b5-1 plan, indicating a pre-scheduled transaction.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While it's a director selling shares, the fact that it's under a Rule 10b5-1 plan mitigates any negative signal, indicating a pre-planned disposition rather than a reactive sale based on new information.

Negatives

• A director's sale of shares, even if pre-planned, reduces insider ownership, which can sometimes be perceived as a neutral to slightly negative signal by investors.

Future Outlook

N/A

Industry Context

This Form 4 filing reports a routine insider transaction for a director at a major clinical laboratory and diagnostic services company. Such transactions are common and often part of personal financial planning, especially when executed under a Rule 10b5-1 plan, which allows insiders to sell shares at pre-determined times or prices to avoid accusations of trading on material non-public information.

Corporate Governance

Related Party Transactions

• Indirect beneficial ownership of shares through the Alexa M. Anderson Separate Trust and Cameron Taff Anderson Separate Trust are disclosed, which are related party holdings.

Stakeholder Impact

• Shareholders: The sale of shares by a director, even if planned, slightly reduces insider ownership, which some investors may monitor as a signal of management's confidence. However, the 10b5-1 plan mitigates any negative interpretation.

Key Dates

Keywords

Labcorp Holdings Inc., LH, Insider Trading, Form 4, Director Share Sale, 10b5-1 Plan, Common Stock, Securities and Exchange Commission, SEC Filing